Table 1.
Association between miR-25 expression and clinicopathologic information of NSCLC patients.
| Clinical parameters | |
miR-25 expression |
|
|
|---|---|---|---|---|
| Total (n = 113) | Low | High | p Value | |
| Sex | 0.46 | |||
| Female | 24 | 18 | 6 | |
| Male | 89 | 65 | 24 | |
| Age | 0.76 | |||
| ≤60 years | 50 | 14 | ||
| > 60 years | 63 | 16 | ||
| Smoking status | 0.14 | |||
| Never | 44 | 12 | ||
| Previous/current | 69 | 18 | ||
| Histological type | 0.48 | |||
| Adenocarcinoma | 92 | 22 | ||
| Squamous carcinoma | 21 | 8 | ||
| TNM Stage | 0.027 | |||
| I/II | 85 | 14 | ||
| III | 28 | 16 | ||
| Lymph node metastasis | 0.001 | |||
| N1 | 83 | 12 | ||
| N0 | 30 | 18 | ||
| Tumor size (cm) | 0.126 | |||
| ≤2 | 37 | 11 | ||
| >2 | 76 | 19 | ||
| Differentiation | 0.24 | |||
| well+ moderate | 70 | 20 | ||
| poor | 43 | 10 | ||